Time-integrated disease activity | 0–6-month progression | 6-month–1-year progression | 1-year–2-year progression | 2-year–3-year progression | ||||
---|---|---|---|---|---|---|---|---|
No | Yes | No | Yes | No | Yes | No | Yes | |
Low (DAS28 < 3.2) | 58 (77.3%) | 17 (22.7%) | 113 (83.1%) | 23 (16.9%) | 100 (77.5%) | 29 (22.5%) | 111 (84.1%) | 21 (15.9%) |
Moderate (DAS28 3.2–5.1) | 79 (73.8%) | 28 (26.2%) | 20 (83.3%) | 4 (16.7%) | 15 (75.0%) | 5 (25.0%) | 8 (61.5%) | 5 (38.5%) |
High (DAS28 > 5.1) | 7 (70.0%) | 3 (30.0%) | 2 (66.7%) | 1 (33.3%) | 0 (0.0%) | 1 (100%) | 1 (100%) | 0 (0.0%) |
Total | 144 (75.0%) | 48 (25.0%) | 135 (82.8%) | 28 (17.2%) | 115 (76.7%) | 35 (23.3%) | 120 (82.2%) | 26 (17.8%) |